###begin article-title 0
The Zinc Transporter SLC39A13/ZIP13 Is Required for Connective Tissue Development; Its Involvement in BMP/TGF-beta Signaling Pathways
###end article-title 0
###begin p 1
Conceived and designed the experiments: TF NC LB RHV AZ JB CR SI ASF TH. Performed the experiments: TF NC TF SS KM YI HK SY SH MN OO HK HGdS LB RHV AZ MEK CR. Analyzed the data: TF TF SS HH YA SY SH LB RHV AZ SU IS. Contributed reagents/materials/analysis tools: TF TF SS KM ASF. Wrote the paper: TF NC SU JB CR SI ASF TH. Joint Senior Authors: IS CR SI ASF TH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Zinc (Zn) is an essential trace element and it is abundant in connective tissues, however biological roles of Zn and its transporters in those tissues and cells remain unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 198 206 198 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 606 614 603 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
Here we report that mice deficient in Zn transporter Slc39a13/Zip13 show changes in bone, teeth and connective tissue reminiscent of the clinical spectrum of human Ehlers-Danlos syndrome (EDS). The Slc39a13 knockout (Slc39a13-KO) mice show defects in the maturation of osteoblasts, chondrocytes, odontoblasts, and fibroblasts. In the corresponding tissues and cells, impairment in bone morphogenic protein (BMP) and TGF-beta signaling were observed. Homozygosity for a SLC39A13 loss of function mutation was detected in sibs affected by a unique variant of EDS that recapitulates the phenotype observed in Slc39a13-KO mice.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 176 184 173 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
Hence, our results reveal a crucial role of SLC39A13/ZIP13 in connective tissue development at least in part due to its involvement in the BMP/TGF-beta signaling pathways. The Slc39a13-KO mouse represents a novel animal model linking zinc metabolism, BMP/TGF-beta signaling and connective tissue dysfunction.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 33 36 33 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Prasad1">[1]</xref>
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Eide1">[2]</xref>
###xml 222 225 222 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Palmiter1">[3]</xref>
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Vallee1">[4]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hirano1">[5]</xref>
###xml 388 391 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kambe1">[6]</xref>
###xml 647 650 647 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kury1">[7]</xref>
###xml 652 655 652 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Wang1">[8]</xref>
###xml 763 766 763 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Vallee2">[9]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Andreini1">[10]</xref>
###xml 881 884 881 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hirano1">[5]</xref>
###xml 967 971 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Bruinsma1">[11]</xref>
###xml 1072 1076 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Taylor1">[12]</xref>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Yamashita1">[13]</xref>
###xml 1456 1460 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kitamura1">[14]</xref>
###xml 1462 1466 1456 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Yamasaki1">[15]</xref>
###xml 1704 1707 1698 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hirano1">[5]</xref>
###xml 279 283 <span type="species:ncbi:10090">Mice</span>
###xml 393 401 <span type="species:ncbi:9606">Children</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
Zn is an essential trace element [1] and its homeostasis in the single cell and in whole organisms is tightly controlled by two major families of Zn transporters, Zn importers (SLC39s/ZIPs) [2] and exporters (SLC30s/ZnTs) [3], and Zn-binding proteins metallothioneins (MTs) [4]. Mice strains carrying mutations in genes related to zinc metabolism show various defects of development [5], [6]. Children affected by the recessive condition acrodermatitis enteropathica (AE) have low serum concentrations of Zn because of mutations in the intestinal Zn transporter SLC39A4/ZIP4. These patients suffer from severe skin disease and frequent infections [7], [8]. Zn is essential for the function of molecules with domains such as Zn-finger, Ring-finger and LIM domains [9], [10]. In addition, Zn has been implicated as signaling molecule or as affecting intracellular signaling pathways [5]. A nematode ZnT1 orthologue, CDF1, positively affects Ras-ERK signal transduction [11]. Slc39a7/Zip7 was found to affect EGF/IGF signaling and tamoxifen resistancy of breast cancer cells [12]. Slc39a6/Zip6/Liv1 controls the nuclear localization of the Zn-finger transcription factor Snail [13]. Extracellular signals, such as toll-like receptor 4 (TLR4)- and FcepsilonR1-mediated stimulation, induce the change of intracellular level of free Zn in dendritic cells and mast cells, respectively, and this in turn controls the biological activities of extracellular stimuli [14], [15]. These reports all support the idea that Zn is an intracellular signaling molecule and lead to the prediction that Zn transporters have roles not only for maintaining Zn homeostasis, but also for mediating intracellular signaling events [5].
###end p 9
###begin p 10
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hambidge1">[16]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Prasad2">[17]</xref>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Bergman1">[18]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Yamaguchi1">[19]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Michaelsson1">[20]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Molokhia1">[21]</xref>
###xml 391 393 391 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MT</italic>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hanada1">[22]</xref>
###xml 699 703 696 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Cobourne1">[23]</xref>
###xml 705 709 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Cao1">[24]</xref>
###xml 711 715 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Yoon1">[25]</xref>
###xml 717 721 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Roberts1">[26]</xref>
###xml 819 823 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Akhurst1">[27]</xref>
###xml 825 829 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Mizuguchi1">[28]</xref>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 723 728 <span type="species:ncbi:9606">Human</span>
In Zn-deficient conditions, bone growth retardation and increase of skin fragility are commonly observed [16], [17]. Indeed, Zn concentrations are high in bone, cartilage, and teeth[18], and Zn may play a role in bone metabolism by stimulating bone formation and mineralization [19]. Zn is also condensed in epidermal and dermal cells and in their extracellular matrix (ECM) [20], [21]. The MT-null mice show low concentration of Zn in skin, and the epidermis fails to exhibit hyperplasia [22]. These evidence suggests an important role of Zn in development of both hard and soft connective tissues, which require well-coordinated local paracrine regulators such as BMP and TGF-beta to be developed [23], [24], [25], [26]. Human genetics studies revealed that they play a pivotal role for connective tissue development [27], [28].
###end p 10
###begin p 11
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Beighton1">[29]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Steinmann1">[30]</xref>
###xml 377 385 377 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Giunta1">[31]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Abu1">[32]</xref>
###xml 1094 1098 1094 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Abu2">[33]</xref>
###xml 627 635 <span type="species:ncbi:9606">patients</span>
The Ehlers-Danlos syndrome (EDS) is a group of genetic disorders affecting connective tissues. Several types are distinguished based on clinical features, inheritance pattern, and molecular basis [29]. Many of them originate from changes in the primary structure or posttranslational modifications of fibrillar collagens [30]. While our studies were in progress, a mutation in SLC39A13 was found in two families with a newly recognized variant of EDS [31], similar to the one we observed in two sibs (see below). In that work, emphasis is given to the impairment in collagen lysyl hydroxylation, a feature observed also in our patients, but no explanation is given for the short stature and other phenotypic features observed, which clearly distinguish the novel EDS type from EDS VIA (procollagen lysyl hydroxylase deficiency). Other EDS types, such as EDS type VIB or EDS type VIID, and related conditions such as the Brittle Cornea Syndrome [32] are still awaiting molecular elucidation; intriguingly, the causative gene for the Brittle Cornea Syndrome has been found to be a Zn-finger gene [33].
###end p 11
###begin p 12
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 166 174 166 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 548 556 545 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Here we report that knockout of Slc39a13 in mice results in a generalized skeletal and connective tissue disorder, and that a homozygous loss of function mutation in SLC39A13 is found in a unique type of the EDS in human subjects. In addition, Slc39a13 controls intracellular Zn distribution and is involved in BMP and TGF-beta signal transduction pathways in connective tissues. Thus, our results allow to establish a genetic and functional link between the Zn transporter Slc39a13 and connective tissue development, showing the usefulness of the Slc39a13-KO mouse as a novel animal model for human connective tissue diseases.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Reduced osteogenesis and abnormal cartilage development in Slc39a13-KO mice
###end title 14
###begin p 15
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 82 101 82 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s002">Figures S1A and S1B</xref>
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 148 158 148 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figures 1A</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s003">S2</xref>
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1B</xref>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 338 347 338 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1C</xref>
###xml 500 509 500 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1C</xref>
###xml 617 627 617 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s004">Figure S3A</xref>
###xml 737 747 737 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s004">Figure S3B</xref>
###xml 989 999 989 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s004">Figure S3C</xref>
###xml 1184 1194 1184 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s004">Figure S3D</xref>
###xml 1223 1231 1223 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
To examine the physiologic role of Slc39a13 in vivo, we performed gene depletion (Figures S1A and S1B). Slc39a13-KO mice showed growth retardation (Figures 1A and S2) and developed progressive kyphosis after 3 or 4 weeks of age (Figure 1B). Slc39a13-KO mice showed several abnormalities in bone: 1) Skull and long bones were radiolucent (Figure 1C, left and middle); 2) Decrease in cortical bone thickness, number of trabeculae, and bone volume (three-dimensional micro-computed tomography (3D-mCT), Figure 1C, right); 3) Decrease in bone mineral density (BMD) in skull, mandible, and cortex and cancellous of femur (Figure S3A); 4) Reduction of bone volume/total tissue volume (BV/TV) and osteoid thickness (O.Th) in tibial metaphyses (Figure S3B); 5) Double-labeling analysis using calcein, a marker of newly formed bone, revealed that calcification activities such as mineral apposition ratio (MAR) and bone formation rate (BFR/BS), an indicator of osteoblast function, were decreased (Figure S3C). However, eroded surface (ES/BS), the numbers of osteoclasts (N.Oc/B Pm), and osteoclast-covered bone surface (Oc.S/BS) were essentially equivalent to those in wild-type littermates (Figure S3D). These data indicated that Slc39a13-KO mice had reduced osteoblast activity with little alteration of osteoclast activity.
###end p 15
###begin title 16
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Growth retardation, kyphosis, osteopenia, and abnormal cartilage development in Slc39a13-KO mice.
###end title 16
###begin p 17
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 304 312 304 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 442 450 442 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 638 645 638 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col10a1</italic>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ihh</italic>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
A. 5-week-old female wild-type and Slc39a13-KO mice. A bar indicates 10 cm. B. Kyphosis in Slc39a13-KO mouse. Appearance and radiographs of 5-week-old mice. C. Osteopenia of Slc39a13-KO mice. X-rays of skull (left), femur and tibia (middle) of 4-week-old mice. 3D-mCT of the tibial diaphysis (right). D. Slc39a13-KO mice show elongated growth plate with uncoordinated columnar formation, and decrease hypertrophic zone. Tibia from 4-week-old Slc39a13-KO mice and wild-type littermates stained with H&E. Large views of growth plate are shown in middle and lower panels. PZ, proliferative zone; HZ, hypertrophic zone. E. Gene expression of Col10a1 and Ihh gene are diminished in growth plate of 4-week-old Slc39a13-KO mice. Bar indicates 300 microm. ISH images.
###end p 17
###begin p 18
###xml 38 46 38 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 104 114 104 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4A</xref>
###xml 158 168 158 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figures 1D</xref>
###xml 173 176 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">S4C</xref>
###xml 304 313 304 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1D</xref>
###xml 402 412 402 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4C</xref>
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col10a1</italic>
###xml 532 541 532 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1E</xref>
###xml 571 576 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr3</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox5</italic>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox6</italic>
###xml 668 676 668 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 694 704 694 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4B</xref>
###xml 757 760 757 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ihh</italic>
###xml 824 832 824 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 847 856 847 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1E</xref>
###xml 984 992 984 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1117 1125 1117 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1143 1153 1143 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4B</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
In addition to decrease of bone mass, Slc39a13-KO mice had a significant reduction in long bone length (Figure S4A). The width of growth plate was elongated (Figures 1D and S4C), where hypertrophic chondrocytes were rarely observed; instead irregularly organized proliferative chondrocytes were present (Figure 1D, bottom right). These abnormalities were apparently observed after 2 or 3 weeks of age (Figure S4C). In Slc39a13-KO chondrocytes, type 10 collagen RNA (Col10a1), a marker for hypertrophic chondrocytes, was diminished (Figure 1E, upper). Expression level of Fgfr3, Sox9, Sox5 and Sox6, all of them crucial for chondrocyte differentiation, were altered in Slc39a13-KO chondrocytes (Figure S4B, left). In addition, expression of Indian hedgehog (Ihh), a marker for the pre-hypertrophic zone, was downregulated in Slc39a13-KO cartilage (Figure 1E, lower). These results strongly suggested that differentiation from proliferative to hypertrophic chondrocytes was impaired in Slc39a13-KO mice. The microarray data also revealed that expression of genes regulating cell adhesion and polarity was diminished in Slc39a13-KO chondrocytes (Figure S4B, right), suggesting a role of Slc39a13 in cellular organization during chondrocytes differentiation.
###end p 18
###begin title 19
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Reduced dentin and alveolar bone, and abnormal craniofacial features in Slc39a13-KO mice
###end title 19
###begin p 20
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 48 57 48 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2A</xref>
###xml 107 116 107 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2A</xref>
###xml 267 276 267 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2C</xref>
###xml 293 302 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2C</xref>
###xml 315 324 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2D</xref>
###xml 386 395 386 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2C</xref>
###xml 599 607 599 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 725 734 725 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2B</xref>
###xml 830 838 830 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 866 875 866 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s006">Figure S5</xref>
###xml 907 915 907 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
Slc39a13-KO mice showed abnormal incisor teeth (Figure 2A): malocclusion, deformity, and breakage (3D-mCT, Figure 2A, lower). They showed reduced root dentine formation of molar teeth and bone volume of both mandible and alveolar (backscattered electron (BEN) image, Figure 2C upper; 3D m-CT, Figure 2C lower; H&E, Figure 2D), with little morphological change in teeth crowns of molar (Figure 2C, upper right). These data indicated an indispensable role of Slc39a13 in the proper development of root dentin, mandible, and alveolar bones. We also noted some changes in the craniofacial morphology of Slc39a13-KO mice. The eyes were sunken, giving an enophthalmos-like appearance, and the palpebral fissures were downslanting (Figure 2B). Measurements of maxilla and mandible bones showed that both bones were remarkably smaller in Slc39a13-KO than in wild-type mice (Figure S5). These results indicated that Slc39a13 has a crucial role for teeth and craniofacial development.
###end p 20
###begin title 21
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Abnormal teeth and craniofacial development in Slc39a13-KO mice.
###end title 21
###begin p 22
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 71 79 71 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 348 356 348 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 527 535 527 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 601 609 601 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 764 772 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 877 885 877 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 953 961 953 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1045 1053 1045 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
###xml 539 544 <span type="species:ncbi:10090">mouse</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 776 780 <span type="species:ncbi:10090">mice</span>
###xml 889 893 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
A. Slc39a13-KO mice develop abnormal incisor teeth (upper). 5-week-old Slc39a13-KO mice show evidence of malocclusion (red arrow head), deformity (blue arrow head), and breakage (yellow arrow head) of incisor teeth. Lower panels show 3D m-CT imaging analysis showing a systemic decrease in bone density and abnormal tooth development of 5-week-old Slc39a13-KO mice compared with wild-type littermates. B. Craniofacial features of Slc39a13-KO mouse. Eye shows enophthalmos-like appearance and downslanting palpebral fissures in Slc39a13-KO mouse. Representative face images of 5-week-old wild-type and Slc39a13-KO mouse. C. Root dentin formation of molar teeth (red arrow head) and the bone volume fraction of mandible (yellow arrow head) are remarkably reduced in Slc39a13-KO mice. BEN (upper) and 3D m-CT images (lower) of mandibular molar regions in 5-week-old wild-type and Slc39a13-KO mice are shown. D. Root dentin and alveolar bone are reduced in Slc39a13-KO mice. Sagittal sections of mandibular molar regions in 5-week-old wild-type and Slc39a13-KO mice were stained with H&E. Boxed areas are reproduced at higher magnification. de: dentin, ab: alveolar bone.
###end p 22
###begin title 23
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Decreased dermal and corneal stromal collagen in Slc39a13-KO mice
###end title 23
###begin p 24
###xml 104 113 104 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3B</xref>
###xml 180 188 180 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 216 225 216 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3A</xref>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 475 492 475 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figures 3D and 3E</xref>
###xml 578 586 578 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 610 619 610 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3A</xref>
###xml 741 749 741 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 782 790 782 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 829 838 829 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3C</xref>
###xml 877 886 877 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3A</xref>
###xml 1002 1010 1002 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1091 1099 1091 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1168 1185 1168 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figures 3F and 3G</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
In addition to hard tissue abnormalities, the strength of skin under tension was significantly reduced (Figure 3B). In fact, dermal collagen fibrils layer was obviously thinner in Slc39a13-KO than in wild-type mice (Figure 3A, lower panels of left and middle). Ultrastructual analysis by transmission-electron micrography (TEM) of dermal collagen fibrils in Slc39a13-KO mice demonstrated significant decrease and wide variation in size compared with those in wild-type mice (Figures 3D and 3E). At the same time, the epidermis layer did not show significant differences between Slc39a13-KO and wild-type mice (Figure 3A, right; enlarged view of blue-box area 1), indicating that the function of collagen-producing cells might be impaired in Slc39a13-KO mice. In fact, morphology of Slc39a13-KO fibroblasts was changed in dermis (Figure 3C, enlarged view of green-box area 2 in Figure 3A); spindle-shaped and often stellate with cytoplasmic extension in wild-type mice, they were mostly round-shaped in Slc39a13-KO mice. In addition to dermis, substantia propria (SP) was markedly thinner in Slc39a13-KO eye, while corneal epithelial cell (CEP) layer was not affected (Figures 3F and 3G). Therefore, Slc39a13 may participate in skin and eye development by controlling dermal and corneal stromal fibroblast functions.
###end p 24
###begin title 25
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Decreased dermal and corneal stromal collagen in Slc39a13-KO mice.
###end title 25
###begin p 26
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 287 295 287 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 351 359 351 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 430 438 430 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 572 581 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3A</xref>
###xml 751 759 749 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 903 911 901 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1099 1107 1097 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1221 1229 1217 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1293 1301 1289 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1475 1483 1471 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1664 1672 1660 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1233 1237 <span type="species:ncbi:10090">mice</span>
A. Dermal collagen is decreased in Slc39a13-KO mice. H&E staining shows 5-week-old Slc39a13-KO skin is thinner than wild-type littermates (left), without significant difference in epidermis (right; enlarged view of blue-boxed area 1). Azan staining shows collagen fibril is decreased in Slc39a13-KO skin (middle). B. Fragility of skin is increased in Slc39a13-KO mice. The strength of skin under tension is weakened in 5-week-old Slc39a13-KO mice compared with wild-type littermates (n = 3 for each). Data represent mean+/-S.D. C. Magnified image of green-boxed area 2 in Figure 3A shows morphology of dermal fibroblasts (red arrow) are spindle-shaped and often stellate with cytoplasmic extension in wild-type, while they are mostly round to oval in Slc39a13-KO mice. D. TEM images of transversely sectioned dermal collagen from 5-week-old mice are shown. Bar; 500 nm. E. Dermal collagen in 5-week-old Slc39a13-KO mice are characterized by thinner in size (left), and lower density of collagen fibrils (right) than that in a wild-type mice. Thirty-nine and 168 areas in TEM images of wild-type and Slc39a13-KO samples, respectively were assessed. Data represent mean+/-S.D. F. Collagen of corneal stroma is decreased in Slc39a13-KO mice. H&E (left) and Azan (middle) staining show 5-week-old Slc39a13-KO cornea is thinner than wild-type littermates. Magnified images of red-boxed area in middle panel show the width of corneal stroma (substantia propia; SP) is decreased in Slc39a13-KO cornea, without significant difference in corneal epithelial cells (CEP) (right). G. Relative ratio between SP versus CEP indicates significant reduction of stromal collagen in Slc39a13-KO cornea compared with those of wild-type (n = 5 for each). Data represent mean+/-S.D.
###end p 26
###begin title 27
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
Mutation of SLC39A13 in Ehlers-Danlos syndrome with short stature and skeletal and connective tissue anomalies
###end title 27
###begin p 28
###xml 196 209 196 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figures 4A&#8211;4F</xref>
###xml 710 719 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figure 4G</xref>
###xml 806 814 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 960 968 960 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 989 997 989 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 1242 1251 1242 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figure 4H</xref>
###xml 1430 1439 1430 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figure 4J</xref>
###xml 1441 1445 1441 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Eide2">[34]</xref>
###xml 1447 1451 1447 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Liuzzi1">[35]</xref>
###xml 1453 1457 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Taylor2">[36]</xref>
###xml 1592 1609 1592 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figures 4I and 4J</xref>
###xml 925 933 <span type="species:ncbi:9606">patients</span>
###xml 972 977 <span type="species:ncbi:10090">mouse</span>
###xml 1934 1939 <span type="species:ncbi:10090">mouse</span>
###xml 1944 1949 <span type="species:ncbi:9606">human</span>
We studied a pair of sibs with short stature and skeletal and connective tissue disease that could not be ascribed to any of the known EDS types or other connective tissue disorders known so far (Figures 4A-4F, and Case reports). We first observed reduced urinary excretion of hydroxylated collagen metabolites, but mutation analysis of several collagen 1 and 3 genes as well as procollagen hydroxylase genes failed to show pathogenic mutations (Case reports). Analysis of the SNP microarray data obtained in the family members revealed a single larger region of complete homozygosity pericentromeric to chromosome 11 (10 Mb encompassing 227 genes). Further screening of this region by microsatellite mapping (Figure 4G) suggested that two parents shared alleloidentical haplotypic blocks. The location of SLC39A13 within the region of homozygosity in combination with the strong analogy between the clinical features in our patients and those observed in the Slc39a13-KO mouse designated SLC39A13 as candidate gene. Mutation analysis showed that both affected individuals were homozygous, and the parents were heterozygous, for a G to A transition at nucleotide c.221 (c.221G>A) predicting the non-conservative amino acid substitution G74D (Figure 4H). UniProt (Universal Protein Resource, ) describes the potential structural topology of SLC39A13/ZIP13 as an eight-transmembrane protein as consistent with other family members (Figure 4J) [34], [35], [36], and glycine -74 is located in the second transmembrane domain of SLC39A13 and conserved through all vertebrate species down to fish (Figures 4I and 4J, and data not shown). Screening of 128 chromosomes of Caucasian descent and an additional 48 chromosomes from Portuguese descent did not reveal any instance of the c.221G>A mutation. Thus, we inferred that c.221G>A/G74D was pathogenic, further establishing the important role of SLC39A13 in connective tissue development in mouse and human.
###end p 28
###begin title 29
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
Clinical features, and genetic and molecular evidence of the SLC39A13 mutation in the two subjects with short stature and EDS.
###end title 29
###begin p 30
###xml 979 987 979 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 1062 1070 1062 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
The elder affected sib is shown at age 22 with short stature and with mildly shortened trunk (A), antimongoloid eye slant with lack of periorbital tissue (B), missing upper lateral incisor tooth (C), thin and finely wrinkled skin on the palm of his hands (D), severe varicosity of his lower legs and feet (E), vertebral flattening with sclerosis of the vertebral endplates (F, radiograph taken at age 18 years). G. Autozygous haplotype blocks detected by SNP genotyping are represented by the black boxes, while blocks detected by microsatellite analyses are represented as solid boxes in different colors (the common ancestral haplotype being represented in red). The microsatellites used are shown on the left, and the numbers refer to microsatellites' alleles. Gene density (GD) for local transcripts is shown in the center. Individual genes are depicted as small circles, shaded (for the olfactory receptor genes clusters) or open (all other genes). The relative position of SLC39A13 and of the centromere (CEN) are also indicated. H. Sequence tracings from SLC39A13 amplicons showing homozygosity for a G to A transition changing codon 74 from glycine to aspartic acid in the two affected subjects (Pat-1 and Pat-2), as well as heterozygosity in the parents. I. Alignment of amino acid sequences of SLC39A13 protein showing high conservation of sequences and in particular of glycine-74 (red box). J. Assignment of transmembrane domains of SLC39A13 (shaded boxes) was taken from Uniprot (). The substitution of glycine-74 with aspartic acid was predicted to cause a six-residue shift of the second transmembrane domain towards the carboxy end by HMMTOP program (, lower panel).
###end p 30
###begin title 31
The Zn transporter Slc39a13 controls intracellular Zn distribution
###end title 31
###begin p 32
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 155 163 155 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 239 249 239 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s002">Figure S1C</xref>
###xml 306 325 306 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figures 5A1 and 5A2</xref>
###xml 349 359 349 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5C2</xref>
###xml 401 410 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5B</xref>
###xml 488 498 488 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5C1</xref>
###xml 578 587 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5D</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Taken together, all results obtained from Slc39a13-KO mice and human cases indicated that Slc39a13 was required for connective tissue development. Indeed, Slc39a13 gene was relatively highly expressed in some tissues such as bone and eye (Figure S1C). This gene was also expressed in osteoblasts of tibia (Figures 5A1 and 5A2) and of alveolar bone (Figure 5C2), in proliferative zone of growth plate (Figure 5B), and in odontoblasts on the forming of the dentine of crown in molar tooth (Figure 5C1). Fibroblasts in reticular layer of dermis of skin expressed Slc39a13 protein (Figure 5D). Collectively, Slc39a13 was expressed in cells essential for connective tissue development.
###end p 32
###begin title 33
Cellular localization of Slc39a13.
###end title 33
###begin p 34
###xml 3 11 3 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 387 395 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 476 484 476 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
A. Slc39a13 gene is expressed in osteoblasts (1 and 2; red arrow head) in tibia of 4-week-old mice. Regions indicated as 1 and 2 in top are magnified as 400 times. ISH images. B. Slc39a13 mRNA is expressed in proliferative zone of growth plate (left) at 3-week-old tibia. Region indicated as 1 and 2 in top are enlarged at lower panels. PZ: proliferative zone. HZ: hypertrophic zone. C. Slc39a13 gene is expressed in odontoblasts of 10-day-old molar teeth. ISH analysis shows Slc39a13 is expressed in odontoblast (black arrowhead) lining the dentin of crown (1), and in osteoblast (red arrowhead) on the surface of alveolar bone (2). Regions indicated as 1 and 2 in top are magnified as 400 times. od: odontoblasts, ab: alveolar bone. D. Slc39a13 protein expression in dermal fibroblasts. IHC analysis shows Slc39a13 protein is expressed in fibroblasts in dermis of 5-week-old wild-type mice (left upper). Enlarged images of boxed areas are shown in IHC images. Bar indicates 10 microm.
###end p 34
###begin p 35
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kambe2">[37]</xref>
###xml 395 404 395 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6A</xref>
###xml 446 455 446 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6B</xref>
###xml 718 726 718 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 865 874 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6C</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Nabarra1">[38]</xref>
###xml 937 945 937 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1016 1025 1016 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6C</xref>
###xml 1178 1182 1178 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kambe2">[37]</xref>
###xml 1810 1819 1810 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6C</xref>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
Slc39a13 belongs to the SLC39/ZIP family of Zn transporters, and therefore is expected to be located on the cell surface and/or on the lumen of intracellular compartments [37], although neither its cellular localization nor its function has been known previously. We found that Slc39a13 protein was localized in perinuclear region of osteoblasts, chondrocytes, pulpal cells, and of fibroblasts (Figure 6A), and mainly located in Golgi apparatus (Figure 6B), suggesting that Slc39a13 protein functions as an intracellular Zn transporter in connective tissue forming cells. Consistent with this hypothesis, while the overall Zn concentration in serum and in dermal fibroblasts as a whole was similar in wild-type and in Slc39a13-KO mice (data not shown), electron probe X-ray micro analysis (EPMA) capable of detecting Zn level in a restricted area of a single cell (Figure 6C, upper) [38] revealed that Zn level in Golgi was increased in Slc39a13-KO primary dermal fibroblasts as compared to that in wild-type cells (Figure 6C, lower right). Considering the fact that members of the SLC39s/ZIPs family function as transporters of Zn from the extracellular space into the cytosol [37], all the evidence supports the notion that this transporter Slc39a13 functions as a Zn transporter transporting Zn from the Golgi to the cytosol and thus influences the Zn level at least in areas of the cytosol, adjacent to the Golgi membrane. We were unable to detect a significant change of the average Zn concentration in the cytosol because apparently, the Zn concentration detected by EPMA was very variable (data not shown); cytosol space is broad and Zn content seems to be heterogeneous from area to area in cytosol. We also found that the Zn concentration in the cell nucleus was decreased in the absence of Slc39a13 (Figure 6C, lower left), implicating that Slc39a13 also affects the nuclear translocation of either Zn-binding proteins, or Zn itself, or both. In their complexity, the results indicate that Slc39a13 affects the intracellular distribution of Zn in connective tissue forming cells.
###end p 35
###begin title 36
Slc39a13 controls intracellular zinc distribution.
###end title 36
###begin p 37
###xml 910 918 910 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 699 701 <span type="species:ncbi:255564">CX</span>
###xml 1012 1014 <span type="species:ncbi:255564">CX</span>
A. Slc39a13 protein locates on perinuclear region in primary osteoblasts (1), chondrocytes (2), pulpal cells (3), and dermal fibroblasts (4). Slc39a13, nuclei, and actin were stained with anti-Slc39a13 specific antibody, DAPI, and phalloidin, respectively. Confocal microscopic images. B. Slc39a13 is localized in Golgi. Confocal microscopic analysis using dermal fibroblasts. Golgi, Slc39a13, nuclei, and actin is stained with anti-GM130 antibody, anti-Slc39a13 specific antibody, DAPI, and phalloidin, respectively. C. Upper: Schematic diagram of EPMA to detect intracellular zinc level. Golgi and nucleus in primary dermal fibroblasts are scanned by electron beam (EB), and characteristic X-ray (CX) for zinc is detected. Lower: Slc39a13 involves in control of intracellular zinc distribution. The ratio of zinc level in Golgi or nucleus versus total Zn in those organelles (n = 11 and 10 for wild-type and Slc39a13-KO dermal fibroblasts, respectively) was obtained by calculating counts per seconds (cps) of CX for zinc generated by EB scanning; Zn level in each organelle (%) = Each organelle Zn (cps)/{nuclear Zn (cps)+Golgi Zn (cps)}x100. Data represents +/-S.D.
###end p 37
###begin title 38
Slc39a13 is involved in BMP/TGF-beta signaling pathways in connective tissue forming cells
###end title 38
###begin p 39
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Draghici1">[39]</xref>
###xml 363 371 360 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 470 480 467 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s007">Figure S6A</xref>
###xml 547 555 544 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scl39a13</italic>
###xml 586 590 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 671 681 668 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s008">Figures S7</xref>
###xml 691 694 688 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s009">S8A</xref>
###xml 722 727 719 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 774 783 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s008">Figure S7</xref>
###xml 833 843 830 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s009">Figure S8B</xref>
###xml 879 887 876 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 928 932 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 934 943 931 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figure 7A</xref>
###xml 950 955 947 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 983 992 980 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figure 7A</xref>
###xml 995 1003 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1062 1077 1059 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">type 1 Collagen</italic>
###xml 1083 1089 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a2</italic>
###xml 1095 1100 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7</italic>
###xml 1143 1152 1137 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figure 7B</xref>
###xml 1189 1197 1183 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1296 1310 1287 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figures 7C, 7D</xref>
###xml 1315 1318 1306 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s011">S10</xref>
###xml 1476 1493 1464 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figures 7C and 7D</xref>
###xml 1685 1693 1673 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 1410 1415 <span type="species:ncbi:10090">mouse</span>
###xml 1506 1511 <span type="species:ncbi:9606">human</span>
###xml 1566 1574 <span type="species:ncbi:9606">patients</span>
###xml 1697 1701 <span type="species:ncbi:10090">mice</span>
To investigate further the consequences of genetic ablation of Slc39a13, we explored molecular events taking place in Slc39a13-KO mice by microarray analysis using primarily isolated osteoblasts and chondrocytes. The pathway-Express program [39] indicated that only BMP/TGF-beta signaling was the cascade that was commonly perturbed in both cell types by loss of Slc39a13 (P-value of hypergeometric distribution with Bonferroni type multiple testing correction, <0.01) (Figure S6A). Consistent with this, we observed changes of gene expression in Scl39a13-KO mice, such as depletion of Msx2, a homeobox gene crucially involved in BMP-mediated bone and teeth development (Figures S7 left and S8A), abnormal accumulation of Runx2, an essential gene for osteoblast maturation (Figure S7, right), and decrease of dermal type 1 collagen (Figure S8B). In addition, BMP4 stimulation in Slc39a13-KO primary osteoblasts failed to induce Msx2 (Figure 7A), and Runx2 was instead overexpressed (Figure 7A). Slc39a13-KO primary dermal fibroblasts showed reduced induction of type 1 Collagen RNA (Col1a2) and Smad7 in response to stimulation with TGF-beta (Figure 7B). Ectopic expression of Slc39a13 in Slc39a13-KO primary osteoblasts and dermal fibroblasts recovered responsiveness against BMP4 and TGF-beta (Figures 7C, 7D and S10), establishing an essential role of Slc39a13 for BMP4 and TGF-beta signaling. Importantly, mouse Slc39a13 carrying the homologous G to A substitution (G74D, Figures 7C and 7D) as well as human SLC39A13 having the G to A mutation obtained from EDS patients (data not shown) was unable to fully rescue the unresponsiveness of osteoblasts and fibroblasts isolated from Slc39a13-KO mice against BMP and TGF-beta, respectively, indicating that this mutation causes a loss of function.
###end p 39
###begin title 40
Slc39a13 is involved in BMP and TGF-beta -mediated signaling.
###end title 40
###begin p 41
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 406 414 400 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 416 422 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col1a2</italic>
###xml 424 429 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smad7</italic>
###xml 435 440 429 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 611 619 602 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 496 501 <span type="species:ncbi:10090">mouse</span>
A. Slc39a13 is involved in BMP4 -mediated gene expression. Primary osteoblasts were stimulated with 50 ng/ml of BMP4 for indicated periods, and gene expression including Slc39a13, Msx2, Runx2, and Gapdh was examined by RT-PCR. B. Slc39a13 is involved in TGF-beta -mediated gene expression. Primary dermal fibroblasts were incubated with 2.5 ng/ml of TGF-beta1 for indicated periods, and gene expression of Slc39a13, Col1a2, Smad7, and Gapdh was examined by RT-PCR. C and D. Ectopic expression of mouse wild-type Slc39a13 (WT), but not of G74D mutant (G74D), rescued BMP4 or TGF-beta -induced gene expression in Slc39a13-KO primary osteoblasts (C) or dermal fibroblast (D), respectively, assessed by real-time PCR. Values represent means+/-S.D. of three separate experiments. E and F. Slc39a13 is involved in BMP/TGF-beta -induced nuclear localization of Smad proteins. Primary osteoblasts (E) or dermal fibroblasts (F) were stimulated with either 50 ng/ml of BMP4 for 15 minutes (E, right panels) or 10 ng/ml of TGF-beta1 for 30 minutes (F, right panels), respectively, followed by staining for Smad1, Smad2/3, nuclei (DAPI), and actin (Actin). Confocal microscopic images.
###end p 41
###begin p 42
###xml 86 90 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Heldin1">[40]</xref>
###xml 92 96 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Miyazono1">[41]</xref>
###xml 346 354 340 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 391 399 385 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 437 447 431 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s007">Figure S6B</xref>
###xml 502 516 496 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figures 7E, 7F</xref>
###xml 521 524 515 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s010">S9C</xref>
###xml 567 591 561 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s010">Figures S9A, S9B and S9D</xref>
###xml 638 646 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 735 754 726 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s010">Figures S9E and S9F</xref>
Smad transcription factors are major signal transducers of BMP and TGF-beta signaling [40], [41]. They are phosphorylated by the activated receptor complex, and subsequently translocate to the nucleus to initiate transcription of their target genes. BMP4 and TGF-beta stimulation induced equivalent phosphorylation level of Smad 1/5/8 (Smads) in Slc39a13-KO osteoblasts and Smad2 (Smad2) in Slc39a13-KO dermal fibroblasts, respectively (Figure S6B). In contrast, nuclear localization of Smad proteins (Figures 7E, 7F and S9C) as well as phosphorylated Smad proteins (Figures S9A, S9B and S9D) was disrupted in BMP4 or TGF-beta-stimulated Slc39a13-KO cells. This was further confirmed by immunoblotting utilizing subcellular fractions (Figures S9E and S9F). These results suggested that Slc39a13 was involved in nuclear localization of Smad proteins, but not for their phosphorylation, in connective tissue forming cells.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 326 335 323 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13-</italic>
###xml 293 298 <span type="species:ncbi:10090">mouse</span>
###xml 303 306 <span type="species:ncbi:9606">man</span>
###xml 338 343 <span type="species:ncbi:10090">mouse</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
We herein described (1) that SLC39A13 is crucially involved in connective tissue development, (2) the emerging role of the Zn transporter SLC39A13 in BMP/TGF-beta signaling in corresponding tissues and cells, (3) that SLC39A13 dysfunction causes skeletal and connective tissue disease both in mouse and man, (4) and thus that Slc39a13-KO mouse is a novel animal model for human connective tissue diseases.
###end p 44
###begin p 45
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 78 88 78 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figures 1C</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s004">S3</xref>
###xml 110 118 110 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figure 7</xref>
###xml 224 229 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 234 238 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 326 330 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Komori1">[42]</xref>
###xml 332 336 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Vainio1">[43]</xref>
###xml 338 342 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Satokata1">[44]</xref>
###xml 344 348 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Nie1">[45]</xref>
###xml 350 354 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Alappat1">[46]</xref>
###xml 375 383 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 455 460 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 465 469 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 485 494 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figure 7A</xref>
###xml 542 549 539 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 551 560 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s008">Figure S7</xref>
###xml 613 617 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Komori1">[42]</xref>
###xml 711 715 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Liu1">[47]</xref>
###xml 840 847 837 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 847 851 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Komori2">[48]</xref>
###xml 853 857 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Shirakabe1">[49]</xref>
###xml 937 941 934 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Ichida1">[50]</xref>
###xml 968 972 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 1074 1082 1071 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1177 1182 1174 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr3</italic>
###xml 1187 1191 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1209 1219 1206 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4B</xref>
###xml 1240 1243 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ihh</italic>
###xml 1258 1267 1255 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1E</xref>
###xml 1308 1313 1305 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgfr3</italic>
###xml 1336 1340 1333 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Naski1">[51]</xref>
###xml 1342 1346 1339 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1388 1392 1385 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox5</italic>
###xml 1397 1401 1394 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox6</italic>
###xml 1413 1417 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Akiyama1">[52]</xref>
###xml 1423 1426 1420 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ihh</italic>
###xml 1482 1486 1479 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kronenberg1">[53]</xref>
###xml 1488 1492 1485 1489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Amano1">[54]</xref>
###xml 1656 1664 1653 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1682 1691 1679 1688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g001">Figure 1D</xref>
###xml 1784 1788 1781 1785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Furuse1">[55]</xref>
###xml 1790 1794 1787 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Shin1">[56]</xref>
###xml 1812 1822 1809 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s005">Figure S4B</xref>
###xml 1893 1901 1890 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1938 1948 1935 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s009">Figure S8A</xref>
###xml 1987 1996 1984 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3C</xref>
###xml 2238 2242 2232 2236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Zavadil1">[57]</xref>
###xml 2366 2374 2360 2368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 2498 2507 2492 2501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2C</xref>
###xml 2865 2869 2859 2863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Thesleff1">[58]</xref>
###xml 2871 2875 2865 2869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Tucker1">[59]</xref>
###xml 2880 2888 2874 2882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 2976 2980 2970 2974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 2982 2992 2976 2986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s009">Figure S8A</xref>
###xml 3091 3095 3085 3089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Thesleff2">[60]</xref>
###xml 3146 3154 3140 3148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3171 3180 3165 3174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g002">Figure 2C</xref>
###xml 3303 3311 3297 3305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3409 3426 3403 3420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figures 3D and 3E</xref>
###xml 3480 3488 3474 3482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3498 3515 3492 3509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figures 3F and 3G</xref>
###xml 3548 3556 3542 3550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3573 3583 3567 3577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figures 3C</xref>
###xml 3588 3590 3582 3584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">7B</xref>
###xml 3668 3676 3662 3670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3763 3767 3754 3758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Roberts1">[26]</xref>
###xml 3769 3773 3760 3764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Ohji1">[61]</xref>
###xml 3775 3779 3766 3770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Sorrell1">[62]</xref>
###xml 3781 3789 3772 3780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3893 3901 3884 3892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3929 3938 3920 3929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g003">Figure 3A</xref>
###xml 4187 4195 4178 4186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 1086 1090 <span type="species:ncbi:10090">mice</span>
###xml 2378 2382 <span type="species:ncbi:10090">mice</span>
###xml 2892 2896 <span type="species:ncbi:10090">mice</span>
###xml 3315 3319 <span type="species:ncbi:10090">mice</span>
###xml 3680 3684 <span type="species:ncbi:10090">mice</span>
###xml 3793 3797 <span type="species:ncbi:10090">mice</span>
###xml 3923 3927 <span type="species:ncbi:10090">mice</span>
###xml 3987 3995 <span type="species:ncbi:9606">patients</span>
###xml 4199 4203 <span type="species:ncbi:10090">mice</span>
Slc39a13-KO mice show osteopenia due to the reduction of osteoblast activity (Figures 1C and S3). As shown in Figure 7, loss of Slc39a13 caused dysregulation of BMP/TGF-beta -mediated gene expression including expression of Runx2 and Msx2, both of which are critically involved in bone, tooth, and craniofacial skeletogenesis [42], [43], [44], [45], [46]. In BMP4-stimulated Slc39a13-KO osteoblasts, we observed simultaneous upregulation and depletion of Runx2 and Msx2, respectively (Figure 7A). This pattern of expression was also observed in vivo (Figure S7). Runx2 is essential for osteoblast differentiation [42], meanwhile it represses functional differentiation of osteoblasts when overexpressed in mice [47], suggesting that proper control of its spatio-temporal expression thus seems to be important for osteoblast differentiation in vivo[48], [49]. Msx2 is reported to promote osteoblast differentiation independently of Runx2 [50]. Therefore, the Slc39a13 -Msx2 gene expression axis may also be critical to lead appropriate skeletal and craniofacial development. Slc39a13-KO mice show evidence of impaired differentiation of chondrocytes in cartilage: expression of Fgfr3 and Sox9 is dysregulated (Figure S4B, left), and that of Ihh is disrupted (Figure 1E, lower). The gain-of-function mutant of Fgfr3 causes achondroplasia [51], Sox9 controls chondrocyte differentiation via Sox5 and Sox6 expression [52], and Ihh is a master gene of bone development under BMP control [53], [54], suggesting that Slc39a13 exerts a profound influence on genes crucial to chondrocyte differentiation. We also found irregular formation of chondrocyte columns in Slc39a13-KO growth plate (Figure 1D, bottom right), where expression of genes required for tight junction and cellular polarity [55], [56] were diminished (Figure S4B, right). The irregularity in cellular morphology was also observed in Slc39a13-KO odontoblasts in the molar tooth (Figure S8A, bottom left) and dermal fibroblasts (Figure 3C); thus, Slc39a13 have a role in growth plate architecture and cellular organization, implicating the possible involvement of Slc39a13 in BMP/TGF-beta signalings since they are well recognized to control cell adhesion, polarity, and movement [57], although we cannot exclude the possibility that other signaling pathways are also affected by loss of Slc39a13. In teeth, Slc39a13-KO mice show reduced normal formation of root dentin in molar but no significant morphological changes in the molar crown (Figure 2C, upper right), suggesting that teeth development normally initiates without Slc39a13 and proceeds until bell stages. From late bell stage, the epithelial and mesenchymal interactions between ameloblasts and odontoblasts are activated, resulting in mineralization, and the root of a tooth begins its development once the crown formation has been established [58], [59]. In Slc39a13-KO mice, odontoblasts cannot sufficiently induce target genes of BMP signaling such as Msx2 (Figure S8A), thus reduction of the width of root dentin may occur since BMP has a crucial role in this stage [60]. Intriguingly, the root was elongated normally in Slc39a13-KO molar tooth (Figure 2C, upper right), suggesting that Slc39a13 is required for root dentin accumulation but not for root elongation. The skin of Slc39a13-KO mice was abnormally fragile, most likely because of the reduction in dermal collagen fibrils (Figures 3D and 3E). Similarly, corneal stromal collagen was reduced in Slc39a13-KO eyes (Figures 3F and 3G). A functional dysregulation of Slc39a13-KO fibroblasts (Figures 3C and 7B) is a plausible reason why both skin and corneal development are impaired in Slc39a13-KO mice, since fibroblasts and TGF-beta are required for their development and repair [26], [61], [62]. Slc39a13-KO mice also showed lipoatrophy; the subcutaneous layer of adipose tissue was significantly thinner in Slc39a13-KO than in wild-type mice (Figure 3A, lower left), a finding present also in the EDS patients (Case reports), suggesting that Slc39a13 may determine the fate of other mesenchymal-originated cells like adipocytes. It is also noteworthy that the physical strength of the ocular bulbs in Slc39a13-KO mice was reduced (data not shown); loss of Slc39a13 may be pathogenically linked to connective tissue disorders associated with fragile eyes.
###end p 45
###begin p 46
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Beighton1">[29]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Steinmann1">[30]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Cabral1">[63]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Barnes1">[64]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Rauch1">[65]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-HaVinh1">[66]</xref>
###xml 307 315 307 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 540 557 540 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g004">Figures 4I and 4J</xref>
###xml 742 745 742 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Wang1">[8]</xref>
###xml 830 847 830 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figures 7C and 7D</xref>
###xml 898 906 898 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 995 1003 995 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1402 1410 1402 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC39A13</italic>
###xml 1444 1448 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Giunta1">[31]</xref>
###xml 2717 2721 2708 2712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Byers1">[67]</xref>
###xml 2723 2727 2714 2718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Neptune1">[68]</xref>
###xml 2795 2803 2786 2794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 3000 3004 2991 2995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hambidge1">[16]</xref>
###xml 3006 3010 2997 3001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Prasad2">[17]</xref>
###xml 3012 3016 3003 3007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Hanada1">[22]</xref>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
###xml 1090 1095 <span type="species:ncbi:10090">mouse</span>
###xml 1113 1118 <span type="species:ncbi:9606">human</span>
###xml 1876 1884 <span type="species:ncbi:9606">patients</span>
###xml 2362 2370 <span type="species:ncbi:9606">patients</span>
###xml 2382 2387 <span type="species:ncbi:10090">mouse</span>
###xml 2554 2559 <span type="species:ncbi:10090">mouse</span>
###xml 2564 2569 <span type="species:ncbi:9606">human</span>
###xml 2779 2787 <span type="species:ncbi:9606">patients</span>
###xml 2807 2811 <span type="species:ncbi:10090">mice</span>
###xml 2838 2843 <span type="species:ncbi:9606">human</span>
###xml 3053 3058 <span type="species:ncbi:10090">mouse</span>
###xml 3076 3081 <span type="species:ncbi:9606">human</span>
These mouse phenotypes of skeletal, dental, dermal, ocular, and craniofacial changes were strongly reminiscent of human EDS and OI [29], [30], [63], [64], [65], [66]. We investigated a pair of sibs who had short stature in combination with skeletal and connective tissue changes that evoked EDS and OI. The SLC39A13 gene was contained in a single region of homozygosity on chromosome 11, and mutation analysis revealed a point mutation predicting the substitution of a highly conserved amino acid (G74D) in the second transmembrane domain (Figures 4I and 4J). A similar substitution of the corresponding glycine (G330) to aspartic acid (G330D) in the first transmembrane domain of SLC39A4/ZIP4 has been associated with the genetic disease, AE[8]. We showed that the homologous mutation in SLC39A13 indeed causes loss of function (Figures 7C and 7D). Accordingly, the individuals homozygous for the SLC39A13 loss of function mutation were affected by a disorder analogous to that observed in the Slc39a13-KO mice and corresponding to the novel EDS variant. Indeed, the recapitulation of the mouse phenotype by the human disorder is extensive, and includes osteopenia, short stature, thin and fragile skin, enophthalmos, thin sclerae, downslanting palpebral fissures and dental anomalies. In agreement with our data, and while our manuscript was being prepared, Giunta et al reported two families with a SLC39A13 mutation and a novel type of EDS [31]. This mutation they found was different from the one we identified but was also predicted to cause loss of function. These authors focused on the reduced excretion of hydroxylysine metabolites and suggest inhibition of lysyl hydroxylase as the probable pathogenetic cause. Indeed, we had also observed reduced urinary excretion of hydroxylated collagen metabolites in our subjects. However, the overall clinical picture of our patients and those described by Giunta et al. is different from that of lysyl hydroxylase deficiency (EDS VIA) with normal stature but severe muscular hypotonia and marked looseness of skin and joints; thus, it is clear that the pathogenetic mechanism postulated by Giunta et al., i.e., secondly inhibition of procollagen lysyl hydroxylase activities, may be operational but does not account for the short stature and the additional features, including hypodontia, observed both in the patients and in the mouse model. The defect in BMP/TGF-beta signaling that we have described is more consistent with the phenotype; impaired TGF-beta signaling fits well with short stature in mouse and human, as increased TGF-beta activity has been regarded as the cause of tall stature in Marfan syndrome, another inherited disorder of connective tissue [67], [68]. Notably enough, some clinical spectrum of the EDS patients and of Slc39a13-KO mice actually resemble that of human cases and animal models of Zn-deficiency, that show developmental abnormalities including dwarfism, bone growth retardation, and increase of skin fragility [16], [17], [22]. Thus, our combined findings in the mouse model and in the human subjects are unequivocable and point to a "Zn - connective tissues - BMP/TGF-beta signaling" connection that deserves thorough exploration.
###end p 46
###begin p 47
###xml 154 168 151 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g007">Figures 7E, 7F</xref>
###xml 174 176 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s010">S9</xref>
###xml 435 439 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Chai1">[69]</xref>
###xml 792 799 783 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc3913</italic>
###xml 864 873 855 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6B</xref>
###xml 1067 1075 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1086 1095 1077 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6C</xref>
###xml 1501 1505 1492 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Peters1">[70]</xref>
###xml 1531 1535 1522 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Liuzzi2">[71]</xref>
###xml 1566 1570 1557 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Dalton1">[72]</xref>
###xml 1991 1995 1982 1986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Rosenzweig1">[73]</xref>
###xml 755 760 <span type="species:ncbi:9606">human</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
Our data showed Slc39a13 is involved in BMP/TGF-beta signaling pathways in connective tissue forming cells and in nuclear translocation of Smad proteins (Figures 7E, 7F, and S9). Smad proteins are phosphorylated downstream of BMP or TGF-beta receptor complex, followed by nuclear translocation. Among the Smad proteins, all receptor-regulated Smad (R- Smad) and Smad4 possess a Zn-binding motif in the MH1 domain for their DNA binding [69]. At the moment, we do not know how Slc39a13 regulates the nuclear localization of Smad proteins, but our results show that the Zn transporter Slc39a13 affects either directly or indirectly BMP and TGF-beta signaling pathways. Considering the fact that there was no change of serum Zn concentration in both cases of human patients (Case reports) and of Slc3913-KO mice (data not shown) and that Slc39a13 is located in Golgi (Figure 6B), it seems likely that Slc39a13 regulates the intracellular Zn distribution. In fact, the Zn concentration at the whole-cell level was unchanged, but the Zn level in the Golgi was increased in Slc39a13-KO cells (Figure 6C, lower right), indicating that Slc39a13 functions as a Zn transporter allowing for efflux of Zn from the Golgi into the cytoplasm, where Zn is expected to interact with Smad. Our data supported that Slc39a13 functions as a Zn transporter controlling intracellular Zn distribution, although we cannot exclude the possibility that Slc39a13 may transport other metals, like Slc39a2/Zip2 for iron and calcium [70], Slc39a14/Zip14 for iron [71], and Slc39a8/Zip8 for cadmium [72]. At the moment it remains unknown how Zn is transferred to its target molecule. It may be simplistic to assume that Zn transporters such as Slc39a13 simply shuttle Zn ions across the Golgi membrane, and that their effect is the result of changes in the concentration of Zn in one or the other cell compartment. Or, unknown "metal chaperone(s)" may transfer Zn directly from a given Zn transporter to Zn binding molecule [73]. The mechanisms how Slc39a13 regulates the nuclear localization of Smad proteins should be an intriguing novel question, and the demonstration of a complex perturbation of intracellular signaling and of deregulation of gene expression in Slc39a13-ablated tissues and cells indicates avenues for further research.
###end p 47
###begin p 48
###xml 40 48 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 553 561 550 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 596 604 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 725 733 719 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 742 746 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Kishigami1">[74]</xref>
###xml 801 809 795 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 877 885 868 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1021 1030 1009 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13-</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 582 590 <span type="species:ncbi:9606">patients</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
Taken together, the results obtained in Slc39a13-KO mice and patients with EDS establish that the Zn transporter SLC39A13 controls intracellular Zn distribution and is involved in connective tissue development. We showed SLC39A13 is required for full activation of BMP and TGF-beta signaling through controlling the intracellular localization of Smad in connective tissue forming cells. This would be at least one of the possible reasons why linear growth, bone mineralization, root dentin formation, and fibroblastic collagen synthesis are impaired in Slc39a13-KO mice and the EDS patients. The Slc39a13-KO phenotype, however, seems to differ from typical BMP/TGF-beta related-KO mice which show more severe phenotypes than Slc39a13-KO mice [74]. This could be explained in the following ways: 1) In Slc39a13-KO, BMP/TGF-beta signaling is affected only in those tissues where Slc39a13 is expressed and functions non-redundantly. 2) In BMP or TGF-beta related-KO mice, all tissues are defective of their signaling. 3) In Slc39a13-KO mice, in addition to BMP/TGF-beta signaling, other signaling pathways might be affected; all of these issues should be unfolded in the future. Our study yields new insights into the relevance of Zn transporters in the biological events, and illustrates their role in health and disease. Thus, further exploration of the role(s) of Zn transporters and of their dysfunction will reveal the role(s) of Zn as a signaling molecule, shed light on other genetic disorders of connective tissue, and help to understand the pathophysiology of Zn-deficiency.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation of Slc39a13 -KO mice
###end title 50
###begin p 51
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Joyner1">[75]</xref>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Nakayama1">[76]</xref>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neo</italic>
###xml 403 411 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 448 458 448 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s002">Figure S1A</xref>
###xml 547 550 547 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Eide1">[2]</xref>
###xml 1165 1175 1165 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s002">Figure S1B</xref>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 985 990 <span type="species:ncbi:10090">mouse</span>
Generation of knockout mouse line of the Slc39a13 gene was performed using previously described methods [75]. A bacterial artificial chromosome (BAC) clone containing the mouse Slc39a13 was screened from an embryonic stem (ES) cell-BAC library [76]. A targeting vector was created to eliminate the genomic region encompassing exons 6-8 by inserting a Neo-cassette into a region between exons 5 and 9 of Slc39a13 and deleting the intervening exons (Figure S1A). This region contains the conserved HEXPHEXGD motif common to SLC39/ZIP family members [2]. This vector was introduced into R1 ES cells and cloned homologous recombinants were selected with antibiotics and the genotypes verified. We developed chimeric mice with the targeted ES cell clones and obtained homozygous mice by interbreeding the offspring. Heterozygous mice were phenotypically normal, and crosses between heterozygotes produced homozygous mutant mice according to Mendelian expectations. All procedures including mouse handling were conducted according to guidelines approved by the RIKEN Institutional Animal Care and Use Committee. Genotyping was done by PCR using LA taq (TAKARA BIO Inc.) (Figure S1B). Primers used for genotyping are;
###end p 51
###begin p 52
###xml 3 39 3 39 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTGTAGCCCACCAATCAGAGACCGATGAT-3&#8242;</named-content>
F; 5'-CTTGTAGCCCACCAATCAGAGACCGATGAT-3'
###end p 52
###begin p 53
###xml 4 31 4 31 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTGGTCAGAAGCCCGATCT-3&#8242;</named-content>
R1; 5'-TGGTGGTCAGAAGCCCGATCT-3'
###end p 53
###begin p 54
###xml 4 40 4 40 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCTGCTAAAGCGCATGCTCCAGACTGCCTT-3&#8242;</named-content>
R2; 5'-GCTGCTAAAGCGCATGCTCCAGACTGCCTT-3'
###end p 54
###begin title 55
X-ray analysis of bones and teeth, and bone histomorphometry
###end title 55
###begin p 56
###xml 495 502 495 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1319 1323 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Parfitt1">[77]</xref>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
Radiographs, BMD, measurement of long bone length, and 3D-mCT scans of bone were taken using a composite X-ray analyzing system (In vivo 3D Micro X-ray CT System R_mCT, Rigaku). The dissected mandibles were scanned using micro CT (MCT-100 MFZ, HITACHI). BEN was scanned using Electron Probe X-ray Micro Analyzer (JXA9200 II, JOEL). Bone histomorphometric analysis was performed by using the left tibia from 4-week-old mice (n = 5) injected with calcein (Wako Pure Chemical Industries, Ltd.) for in vivo fluorescent labeling (16 mg/kg body weight/10 ml) at 1 and 4 days before sacrifice. The tibia was fixed in 70% ethanol, and the undercalcified bone were embedded in Glycolmetacrylate. 3-micrometer-thick section was cut longitudinally in the proximal region of the tibia, and stained for toluidine-blue-O and tartrate-resistant acid phosphatase (TRAP). Histomorphometry was performed with the semiautomatic image analyzing system (Osteoplan II; Carl Zeiss) linked to a light microscope. The histomorphometric measurements were made at 400 times using a minimum of 17approximately20 optical fields in the secondary spongiosa area from the growth plate-metaphyseal junction. Nomenclature, symbols, and units used are those recommended by the Nomenclature Committee of the American Society for Bone and Mineral Research [77].
###end p 56
###begin title 57
Skeletal and teeth histology
###end title 57
###begin p 58
###xml 200 207 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 274 282 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 284 288 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Msx2</italic>
###xml 290 295 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Runx2</italic>
###xml 297 304 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Col10a1</italic>
###xml 310 313 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ihh</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Paraffin sections (4approximately6 microm) processed from tibia of 1, 2, 3 and 4-week-old mice, mandible of 5-week-old mice, and molar tooth of 10 day-old mice were prepared for H&E staining, and for in situ hybridization (ISH). Digoxigenin-labeled antisense RNA probes for Slc39a13, Msx2, Runx2, Col10a1, and Ihh were used for ISH by the method of GENOSTAFF Inc. The sections used in ISH analysis were counterstained with Kernechtrot stain solution. Probe sequences and hybridization conditions are available upon request.
###end p 58
###begin title 59
Skin and eye histomorphometry
###end title 59
###begin p 60
###xml 379 388 375 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5D</xref>
###xml 429 437 425 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g006">Figure 6</xref>
###xml 562 570 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 593 602 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003642-g005">Figure 5D</xref>
###xml 790 791 786 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 978 986 974 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1033 1037 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Birk1">[78]</xref>
###xml 1282 1283 1278 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 238 244 <span type="species:ncbi:9986">rabbit</span>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
###xml 639 645 <span type="species:ncbi:9986">rabbit</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1400 1404 <span type="species:ncbi:10090">mice</span>
Skin and eye isolated from 5-week-old mice were formalin-fixed and paraffin-embedded. Paraffin sections (4 microm) were cut and stained with H&E and Azan for histological analysis, and also used for immuno histochemistry (IHC). We made a rabbit polyclonal antibody specific to a peptide corresponding to the CLAQPAAEPGLRAVVRNL sequence of mouse Slc39a13, which was used for IHC (Figure 5D) and for confocal microscopic analysis (Figure 6). We confirmed that this antibody was able to detect and was specific to Slc39a13 since it did not show positive signals in Slc39a13-KO cells, as shown in Figure 5D. For collagen type I staining, anti-rabbit polyclonal antibody against collagen I (Abcam) was used. To measure the fragility of skin, dorsal skin of 5-week-old mice were chopped in 2x3 cm2, and the strength of skin under tension was measured by a spring scale. For transmission electron microscopy, skin biopsy samples were taken from dorsal skin of 5-week-old wild-type and Slc39a13-KO mice, and prepared as previously described [78]. For measurement of collagen fibril density, the superficial dermis was photographed in the central portion, and diameters were measured along the minor axis of cross-sections using Image-Pro Plus (Media Cybernetics). Quantitation of fibrils/nm2 was also measured from transmission electron micrographs of cross-sections from dermis of the dorsal skin region of mice using Image-Pro Plus (Media Cybernetics).
###end p 60
###begin title 61
Confocal microscopy and immunoblotting
###end title 61
###begin p 62
###xml 1297 1306 1291 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s007">Figure S6</xref>
###xml 1321 1331 1315 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s007">Figure S6B</xref>
###xml 1408 1416 1402 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 675 679 <span type="species:ncbi:9925">goat</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 754 758 <span type="species:ncbi:9925">goat</span>
###xml 764 770 <span type="species:ncbi:9986">rabbit</span>
###xml 1148 1154 <span type="species:ncbi:9986">rabbit</span>
###xml 1246 1251 <span type="species:ncbi:10090">mouse</span>
Cells cultured on glass coverslips in 35-mm Glass base dishes (Iwaki) were stimulated and then fixed with 4% paraformaldehyde in PBS. Immunostaining was done after cells were made permeable with BD Perm/Wash Buffer containing antibodies and 1% BSA. Fluorescence was detected with an inverted spectral Confocal Scanning system TCS SP2 AOBS (Leica) with an oil immersion 63x objective. Images were processed with Adobe Photoshop Version 7.0. GM130 antibody (clone35, BD Transduction Laboratories), DAPI (Molecular Probes), and Alexa Fluor(R)546 phalloidin (Molecular Probes) were used to visualize Golgi, nuclei, and actin, respectively. Alexa Fluor(R) 568 F(ab')2 fragment of goat anti-mouse IgG (Molecular Probes), Alexa Fluor(R) 488 F(ab')2 fragment of goat anti-rabbit IgG (Molecular Probes) were used for secondary staining. The following antibodies were used for confocal microscopy and immunoblotting; anti-Smad1 (Zymed), anti-Smad2/3 (BD Transduction Laboratories), anti-phosphorylated Smad1/5/8 (Cell Signaling), and anti-phosphorylated Smad2 (Cell Signaling). Anti-tubulin (B-5-1-2, Sigma), anti-Flag (Sigma), anti-HDAC1 (Sigma). We made a rabbit antibody by immunization with a peptide corresponding to the NSKEDPSQAPSKDPTAA sequence of mouse Slc39a13, which was used for immunoblotting (Figure S6). As shown in Figure S6B, this antibody reacted with a 40 kDa molecule in wild type cells but not in Slc39a13-KO cells. BMP4 and TGF-beta1 were purchased from R&D systems.
###end p 62
###begin title 63
Subcellular fractionation
###end title 63
###begin p 64
Cells were stimulated with BMP4 or TGF-beta1 for indicated periods, and then were lysed with hypotonic buffer (20 mM HEPES pH 7.9, 0.1 mM EDTA, 0.2% NP-40, 10 mM NaCl, 1 mM DTT) supplemented with proteinase inhibitors for 5 min. After centrifugation at 10,000xg for 1 min, cytoplasmic fraction was isolated as supernatant. Precipitates were then incubated with extraction buffer (20 mM HEPES pH 7.9, 0.1 mM EDTA, 0.2% NP-40, 420 mM NaCl, 1 mM DTT) supplemented with proteinase inhibitors at 4degreesC for 30 min. Nuclear fraction was subsequently extracted by centrifugation (10,000xg, 4degreesC, 10 min). For total cell lysates, cells were suspended with lysis buffer (1% NP-40, 20 mM Tris-HCl pH 7.4, 150 mM NaCl) supplemented with proteinase inhibitors, and lysates were cleared by centrifugation (10,000xg, 4degreesC, 10 min). 20 microg of each fraction were subjected to SDS-PAGE, followed by immunoblotting.
###end p 64
###begin title 65
Measurement of zinc distribution in cell
###end title 65
###begin p 66
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
Electron Probe X-ray Micro Analyzer (JXA9200 II, JOEL) assessed intracellular zinc distribution in primary dermal fibroblasts. Wild-type and Slc39a13-KO dermal fibroblasts were cultured in 6 well plates, and cells were fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and post-fixed in 1% osmium tetroxide. Subsequently, the cells were dehydrated in an ascending series of alcohol and embedded in epoxy resin. Electron beam scanned Golgi and nucleus of embedded cells. Characteristic X-ray for zinc generated by electron beam exposure was detected.
###end p 66
###begin title 67
Gene expression profiles
###end title 67
###begin p 68
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 528 536 528 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Slc39a13</italic>
###xml 1193 1202 1193 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s013">Tables S2</xref>
###xml 1207 1209 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s014">S3</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 287 292 <span type="species:ncbi:10090">Mouse</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
Gene expression profiling was conducted using total RNAs obtained from primary osteoblasts and chondrocytes of wild-type and Slc39a13-KO mice. Biotinylated cRNA was synthesized using a One-Cycle Target Labeling kit (Affymetrix) according to the manufacturer's manual and hybridized with Mouse Genome 430 2.0 Arrays (Affymetrix). The signal intensities for each probe set were calculated using a gcRMA method in a Genespring GX 7.3 software package (Agilent). Using lists of genes exhibiting 2-fold changes between wild-type and Slc39a13-KO cells, pathway analysis was conducted on a Pathway Express program (). The raw data for microarray analysis are available from the Gene Expression Omnibus (GEO) of the National Center for Biotechnology Information (NCBI; series accession nos. GSE10555 and GSE10556). For RT-PCR analysis, total RNA was extracted from cells and several tissues of C57/B6J mice using Sepasol-RNA I (Nacalai tesque), and reverse-transcribed with oligo-(dT) primer and a reverse transcriptase (ReverTra Ace, TOYOBO). SYBR Green PCR Master Mix (Applied Biosystems) was used for real-time PCR analysis. Primer sequences for RT-PCR and real-time PCR are listed in Supplemental Tables S2 and S3, respectively.
###end p 68
###begin title 69
Statistics analysis
###end title 69
###begin p 70
Differences among multiple groups were compared by 1-way ANOVA followed by a post-hoc comparison using Fisher's PLSD test. The two-tailed Student's test was used to analyze difference between 2 groups.
###end p 70
###begin title 71
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human studies
###end title 71
###begin p 72
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 446 453 <span type="species:ncbi:9606">patient</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
###xml 1291 1296 <span type="species:ncbi:9606">Human</span>
###xml 1496 1504 <span type="species:ncbi:9606">patients</span>
###xml 1510 1518 <span type="species:ncbi:9606">patients</span>
The committee approved the studies and confirmed that informed consent was obtained from human subjects as follows: The patients were not recruited in a prospective study, but came to us with a request for diagnostic help and genetic counseling owing to our reputation as medical experts in skeletal and connective tissue diseases. We have seen them at the Lausanne University Hospital. Thus, our relationship with them falls under the physician-patient relationship as defined by Swiss law; every single procedure (clinical examination, venipuncture, radiography and skin biopsy) is directly related to the diagnostic procedure and is not per se a research procedure. Equally, analysis of the patients' biologic material (urine, blood, DNA, cell culture) is part of the routine diagnostic procedure to confirm or rule our known genetic entities (in our case, the known forms of Ehlers-Danlos syndromes). Although written consent is required only for surgical operation with anaesthesia, which was not performed in our case, we obtained both oral and written informed consent. The IRB has granted approval for the informed consent for research procedures of this type (i.e., non-surgical) to all activities performed within the Swiss National Foundation research project "Molecular Bases of Human Chondrodysplasias" (PIs: A. Superti-Furga and L. Bonafe). This is to cover for the performance of additional procedures such as the sequencing of "novel" genes and the study of cell cultures in such patients. The patients themselves (two well-informed young adults) have enthusiastically (and thankfully) given oral and written informed consent to study their DNA and cells hoping for results that could help in therapy and/or genetic counseling.
###end p 72
###begin title 73
Case reports
###end title 73
###begin title 74
Clinical characterization of a novel type of Ehlers-Danlos syndrome
###end title 74
###begin p 75
###xml 2311 2315 2311 2315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Beighton1">[29]</xref>
###xml 2317 2321 2317 2321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Steinmann1">[30]</xref>
###xml 2323 2327 2323 2327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Pepin1">[79]</xref>
###xml 1894 1902 <span type="species:ncbi:9606">patients</span>
We identified a sib pair, a male and a female, with short stature and a combination of skeletal and connective tissue findings that could not be classified in existing nosologic categories. Briefly, these individuals were born at term from uncomplicated pregnancies. The parents were not knowingly related but originated from the same region in Portugal; they were healthy and of average stature. Both sibs were of normal size and weight at birth but showed progressive short stature beginning in the second half of the first year of life. Among the clinical signs at that time were muscular hypotonia and soft skin, leading to the diagnostic suspicion of the Ehlers-Danlos Syndrome (EDS). During childhood, the main clinical signs and features were thin, fragile, but not hyperelastic skin that bruised easily and was particularly thin on the hands and feet; varicose veins; moderate joint laxity; blueish or greyish sclerae; downslanting palpebral fissures; and hypodontia of one or a few teeth in permanent dentition. Both had astigmatism in childhood. Radiographic examination revealed moderate osteopenia, flattened or biconcave vertebral bodies with flaky irregularity of the endplates as well as mild dysplastic changes at the metaphyses of long bones and of the phalanges. As adults, the affected male and female subjects were, respectively, 145 and 135 cm tall; their body proportions were normal, indicating that the platyspondyly was accompanied by shortening of the long bones. Their skin remained thin and fragile, and the subcutaneous fat tissue was sparse. Both individuals had marked venous varicosities on their feet and legs. The male subject suffered from a cerebral hemorrhage posteriorly to the left putamen at age 21 years, from which he recovered completely. Intellectual development was above average, and there was no history of susceptibility to infections. Thus, the patients had features of the EDS, in particular of EDS type IV (thin and fragile skin, varicose veins, cerebral hemorrhage) and some signs of osteogenesis imperfecta (flattened or biconcave vertebrae and grayish sclerae), but the degree of short stature was unusual, and the facial appearance with downslanting palpebral fissures as well as the dysplastic vertebral bodies similarly did not fit either diagnosis well [29], [30], [79].
###end p 75
###begin title 76
Biochemical characterization of the novel type of Ehlers-Danlos syndrome
###end title 76
###begin p 77
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s012">Table S1</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-AlHussain1">[80]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003642-Steinmann2">[81]</xref>
###xml 1030 1035 <span type="species:ncbi:10090">mouse</span>
Routine analysis of collagen synthesis in cultured fibroblasts was normal, ruling out a diagnosis of EDS IV and making OI unlikely. Analysis of the urinary excretion of collagen crosslinks revealed that both individuals excreted a reduced ratio of hydroxylated vs. unhydroxylated collagen crosslink products in their urine (Supplemental Table S1). The reduction was statistically significant when compared to that of either parent, but was milder than that observed in lysyl hydroxylase deficiency (EDS type VIA)[80], [81]. A therapeutic trial of vitamin C administered orally at a dose of 1 g/day for one month to stimulate procollagen lysyl hydroxylation in the two affected individuals did not change the urinary excretion pattern. After elucidation of the SLC39A13 mutations, Zn levels were determined twice in both affected individuals in plasma and in urine to test for a possible perturbation of whole-body Zn homeostasis; the Zn levels were within the normal range for adults. This may be consistent with the finding that mouse Slc39a13 is located in the Golgi and therefore SLC39A13 likely regulates the intracellular Zn distribution.
###end p 77
###begin title 78
Linkage and mutation analysis of the family with the novel type of Ehlers-Danlos syndrome
###end title 78
###begin p 79
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLOD1</italic>
###xml 424 429 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLOD2</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLOD3</italic>
###xml 509 515 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A1</italic>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL3A1</italic>
###xml 537 542 537 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRTAP</italic>
Based on the slightly but consistently reduced excretion of hydroxylated collagen crosslink products, we first hypothesized that this condition was either a variant of EDS VIA or another enzymatic deficiency leading to impaired procollagen lysyl hydroxylation, but extensive linkage analysis under a model of recessive inheritance and targeted mutation analysis excluded the three procollagen lysyl hydroxylase genes PLOD1, PLOD2, and PLOD3 as responsible for the disease; further studies excluded the genes, COL1A1, COL1A2, COL3A1, and CRTAP.
###end p 79
###begin title 80
Supporting information
###end title 80
###begin p 81
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003642.s001">Text S1</xref>
###xml 160 165 <span type="species:ncbi:9606">human</span>
Information for plasmid construction and transfection, skeletal staining, primary cell culture condition, measurement of maxilla and mandibles, and analysis of human biological samples was described in Text S1.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
(0.68 KB DOC MB )
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 250 257 <span type="species:ncbi:9606">Infants</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
Generation of Slc39a13-KO mice. A. Schematic diagram of the construct used to generate Slc39a13-KO mice. A targeting vector was constructed with a Neo-cassette inserted into the region between exons 5 and 9 of Slc39a13 locus. TK: thymidine kinase B. Infants produced by crosses between heterozygotes were genotyped by PCR using specific primers (F, R1 and R2, shown in Figure S1A). WT: wild-type, HE: heterozygote, KO: Slc39a13-KO. C. Slc39a13 gene expression in mouse tissues assessed by RT-PCR. sLN: superficial inguinal lymph node, mLN: mesenteric lymph node, BM: bone marrow cells, DeltaBM: without bone marrow cells.
###end p 85
###begin p 86
(0.73 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
Growth retardation of Slc39a13-KO mice. A. Left: Little significant difference in skeletogenesis and body size at newborn between wild-type and Slc39a13-KO mice. Bar indicates 1 cm; Right: Body weight of newborn mice (n = 5 for each). Data represent mean+/-S.D. B. Significant delayed growth is observed after 3 weeks of age (n = 5; male mice). Data represent mean+/-S.D. C. Both male and female Slc39a13-KO mice show growth retardation (n = 10 for each). Data represent mean+/-S.E.M. WT: wild-type mice, HE: heterozygote mice, KO: Slc39a13-KO mice.
###end p 88
###begin p 89
(1.41 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
Skeletal histomorphometry of Slc39a13-KO mice. A-D: Bone histomorphometric analysis. Data represent mean+/-S.D. A. BMD (bone mineral density) in skull, mandible, cortex, and cancellous zone of femur are decreased in 5-week-old Slc39a13-KO mice compared with wild-type mice (n = 5 for each). B. Bone volume and osteoid thickness of 4-week-old Slc39a13-KO mice are lower than those of wild-type (n = 5 for each). C. Osteoblast function is significantly decreased in Slc39a13-KO mice. A double-labeling analysis of calcein (left), mineral apposition ratio (middle), and first and second calcein bone formation rate (right) of 4-week-old mice (n = 5 for each). D. Osteoclast activity of Slc39a13-KO mice is equivalent to wild-type littermates. Eroded surface (left), osteoclast number (middle), and osteoclast-covered bone surface (right) of 4-week-old Slc39a13-KO and wild-type mice are shown (n = 5 for each).
###end p 91
###begin p 92
(0.94 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
Abnormal cartilage development in Slc39a13-KO mice. A. Length of femur (upper) and tibia (lower) of 4-week-old Slc39a13-KO mice are shorter than those of wild-type (n = 5 for each). Data represent mean+/-S.D. B. Genes involved in chondrocyte differentiation (left) and in cell adhesion or polarity (right) are dysregulated in Slc39a13-KO primary chondrocytes. Gene expression profiling by DNA microarray analysis was carried out using total RNA from Slc39a13-KO or wild-type primary chondrocytes. Each gene was normalized to the median of the measurement for that gene. C. Abnormal morphology of growth plate in Slc39a13-KO mice. H&E staining images are shown. PZ: proliferative zone. HZ: hypertrophic zone. Bar indicates 100 microm.
###end p 94
###begin p 95
(4.46 MB TIF
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 700 704 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
Impaired craniofacial skeletogenesis in Slc39a13-KO mice. A. The following points are traced on the cephalometric radiographs: Upper; Ba, Basion, defined as the most posterior-inferior cephalometric maxilla point; Rh, Rhinion, the most anterior point of the nasal bone; and Na, Nasion, the cephalometric point between the nasal bone and the frontal bone. Lower; Me, Menton, the lowest point of the chin; Go, Gonion, the most posterior inferior point at the angle of the mandible; and Co, Condylion, the most posterior superior point on the condyle of the mandible. B-F. Dwarfed craniofacial formation in Slc39a13-KO mice. Analysis of the 5-week-old maxilla and mandible bone reveals that Slc39a13-KO mice are characterized by shorter craniofacial depth (B. Ba-Rh), shorter nasomaxillary depth (C. Na-Rh), shorter cranial base depth (D. Na-Ba), shorter mandibular depth (E. Me-Go), and shorter craniofacial depth (F. Me-Co), compared with wild-type mice (n = 5 for each). Data represent mean+/-S.D.
###end p 97
###begin p 98
(0.75 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
Perturbation of BMP/TGF-beta signal transduction without affecting phosphorylation of Smad proteins in Slc39a13-KO cells. A. DNA microarray analysis using RNA of primary osteoblasts (left) and chondrocytes (right). Each gene was normalized to the median of the measurement for that gene. B. Smad proteins are normally phosphorylated in Slc39a13-KO cells. Primary osteoblasts or dermal fibroblasts were stimulated with either 50 ng/ml of BMP4 (left), or 10 ng/ml of TGF-beta1 (right), respectively for indicated periods. Total cell lysates were separated by SDS-PAGE, followed by immunoblotting with either anti-phosphorylated Smad1/5/8 (pSmads), anti-Smad1, anti-phosphorylated Smad2 (pSmad2), anti-Smad2/3, or anti-Scl39a13 specific antibodies. Anti- alpha -tubulin antibody was used for control blotting.
###end p 100
###begin p 101
(0.84 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Dysregulated expression of tibial Msx2 and Rnux2 in Slc39a13-KO mouse. ISH analysis shows Runx2 is accumulated (right), while Msx2 is diminished (left) in 4-week-old Slc39a13-KO tibia. Regions indicated as 1 and 2 in upper are enlarged as 200 times at middle and lower panels.
###end p 103
###begin p 104
(8.41 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
Dysregulated expression of molar Msx2 and dermal type 1 collagen expression in Slc39a13-KO mouse. A. ISH analysis shows Msx2 gene expression is diminished in odontoblasts (od) lining the dentin of crown (bigstar) of 10-day-old Slc39a13-KO molar teeth. Regions indicated with bigstar in upper are enlarged as 200 times at lower panels. Unorganized odontoblasts are observed in Slc39a13-KO molar. B. Type I collagen level is decreased in Slc39a13-KO skin. Skin section of 5-week-old wild-type and Slc39a13-KO mice were applied for IHC. Bar indicates 100 microm.
###end p 106
###begin p 107
(5.71 MB TIF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
Involvement of Slc39a13 in localization of Smad proteins. A and B. Slc39a13 is involved in BMP/TGF-beta -induced nuclear localization of phosphorylated Smad proteins. Primary osteoblasts (A) or dermal fibroblasts (B) were stimulated with either 50 ng/ml of BMP4 for 15 minutes (A, right panels) or 10 ng/ml of TGF-beta1 for 30 minutes (B, right panels), respectively, followed by staining for phosphorylated Smad1/5/8 (pSmads), phosphorylated Smad2 (pSmad2), nuclei (DAPI), and actin (Actin). Confocal microscopic images are shown. C and D. Ratio of subcellular localization of intact (C) or phosphorylated (D) Smad proteins was obtained by counting cells (n = 50) in confocal microscopy images visualized by anti- Smad1, anti-Smad2/3, anti-phosphorylated Smad1/5/8 (pSmad), or anti- phosphorylated Smad2 (pSmad2) antibodies after BMP4 (left in C and D; for Smad1 and pSmads in osteoblasts) or TGF-beta1 (right in C and D; for Smad2/3 and pSmad2 in dermal fibroblasts) stimulation. nuc: nuclear space, cyto: cytoplasmic space, both: both of nuclear and cytoplasmic spaces E and F. Cytoplasmic and nuclear fractions from primary osteoblasts (E) and dermal fibroblasts (F) were separated by SDS-PAGE, followed by immunoblotting with either anti-phosphorylated Smad1/5/8 (pSmads) and anti-Smad1 (E), or anti-phosphorylated Smad2 (pSmad2) and anti-Smad2/3 (F) antibodies. Anti- alpha-tubulin and HDAC1 antibodies were used for control blotting.
###end p 109
###begin p 110
(2.36 MB TIF)
###end p 110
###begin p 111
Click here for additional data file.
###end p 111
###begin p 112
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Ectopic expression of Slc39a13. Either empty vector (mock), Flag-tagged wild-type (WT), or G74D mutated (G74D) mouse Slc39a13 expression plasmids were transfected into Slc39a13-KO primary osteoblasts (A) and dermal fibroblasts (B). Their expression level was assessed by RT-PCR (upper), and by immunoblotting using anti-Flag and anti-alpha-tubulin antibodies at two days after transfection (lower).
###end p 112
###begin p 113
(0.72 MB TIF)
###end p 113
###begin p 114
Click here for additional data file.
###end p 114
###begin p 115
Molar ratio of hydroxylysyl/lysyl-pyridinoline collagen crosslinks in urine of the two sibs with EDS and in their parents.
###end p 115
###begin p 116
(0.71 MB TIF)
###end p 116
###begin p 117
Click here for additional data file.
###end p 117
###begin p 118
Primer sequences used for RT-PCR are listed.
###end p 118
###begin p 119
(0.97 MB TIF)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
Primer sequences used for real time-PCR are listed.
###end p 121
###begin p 122
(0.77 MB TIF)
###end p 122
###begin p 123
Click here for additional data file.
###end p 123
###begin p 124
###xml 325 330 <span type="species:ncbi:9606">human</span>
We thank Dr. Kohei Miyazono (University of Tokyo) for critical reading and variable suggestions and Drs. Ken Watanabe (The National Center for Geriatrics and Gerontology, Obu) and Masahiro Narimatsu (Mount Sinai Hospital, Toronto) for their helpful experimental advice. We are grateful to Dr. Sayaka Tominaga for her help in human genetic analysis, and to Mr. Masami Kawamura and Tsutomu Yamasaki, and Ms Satoko Ojimi, Yuko Ishikura, and Ayumi Ito for their excellent technical assistance. We also thank Ms Mizuki Shimura and Ryoko Masuda as well as Andi Bandi for their secretarial assistance. Dr. Brendan Lee (Baylor College of Medicine, Houston) is acknowledged for CRTAP mutation analysis, and Dr. Peter Byers (University of Washington) for collagen synthesis study in fibroblast cultures.
###end p 124
###begin title 125
References
###end title 125
###begin article-title 126
Zinc: an overview.
###end article-title 126
###begin article-title 127
The SLC39 family of metal ion transporters.
###end article-title 127
###begin article-title 128
Efflux and compartmentalization of zinc by members of the SLC30 family of solute carriers.
###end article-title 128
###begin article-title 129
The function of metallothionein.
###end article-title 129
###begin article-title 130
Roles of zinc and zinc signaling in immunity: Zinc as an intracellular signaling molecule.
###end article-title 130
###begin article-title 131
The genetics of essential metal homeostasis during development.
###end article-title 131
###begin article-title 132
Identification of SLC39A4, a gene involved in acrodermatitis enteropathica.
###end article-title 132
###begin article-title 133
A novel member of a zinc transporter family is defective in acrodermatitis enteropathica.
###end article-title 133
###begin article-title 134
New perspective on zinc biochemistry: cocatalytic sites in multi-zinc enzymes.
###end article-title 134
###begin article-title 135
###xml 42 47 <span type="species:ncbi:9606">human</span>
Counting the zinc-proteins encoded in the human genome.
###end article-title 135
###begin article-title 136
Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling.
###end article-title 136
###begin article-title 137
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in anti-hormone resistant breast cancer cells.
###end article-title 137
###begin article-title 138
###xml 68 77 <span type="species:ncbi:7955">zebrafish</span>
Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer.
###end article-title 138
###begin article-title 139
Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function.
###end article-title 139
###begin article-title 140
Zinc is a novel intracellular second messenger.
###end article-title 140
###begin article-title 141
Zinc deficiency: A special challenge.
###end article-title 141
###begin article-title 142
Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia.
###end article-title 142
###begin article-title 143
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Autoradiographic studies on the distribution of zinc-65 in mice.
###end article-title 143
###begin article-title 144
Role of zinc in bone formation and bone resorption.
###end article-title 144
###begin article-title 145
Zinc in epidermis and dermis in healthy subjects.
###end article-title 145
###begin article-title 146
Neutron activation analysis of trace elements in skin. 3. Zinc in normal skin.
###end article-title 146
###begin article-title 147
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Epidermal proliferation of the skin in metallothionein-null mice.
###end article-title 147
###begin article-title 148
Tooth and jaw: molecular mechanisms of patterning in the first branchial arch.
###end article-title 148
###begin article-title 149
The BMP signaling and in vivo bone formation.
###end article-title 149
###begin article-title 150
Multiple functions of BMPs in chondrogenesis.
###end article-title 150
###begin article-title 151
Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta.
###end article-title 151
###begin article-title 152
TGF beta signaling in health and disease.
###end article-title 152
###begin article-title 153
Heterozygous TGFBR2 mutations in Marfan syndrome.
###end article-title 153
###begin article-title 154
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).
###end article-title 154
###begin article-title 155
The Ehlers-Danlos syndrome.
###end article-title 155
###begin article-title 156
Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome - An autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13.
###end article-title 156
###begin article-title 157
Mapping of a gene causing brittle cornea syndrome in Tunisian jews to 16q24.
###end article-title 157
###begin article-title 158
Deleterious mutations in the zinc-finger 469 gene cause brittle cornea syndrome.
###end article-title 158
###begin article-title 159
Zinc transporters and the cellular trafficking of zinc.
###end article-title 159
###begin article-title 160
Mammalian zinc transporters.
###end article-title 160
###begin article-title 161
The LZT proteins; the LIV-1 subfamily of zinc transporters.
###end article-title 161
###begin article-title 162
Overview of mammalian zinc transporters.
###end article-title 162
###begin article-title 163
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Localization of zinc in the thymic reticulum of mice by electron-probe microanalysis.
###end article-title 163
###begin article-title 164
A systems biology approach for pathway level analysis.
###end article-title 164
###begin article-title 165
TGF-beta signalling from cell membrane to nucleus through SMAD proteins.
###end article-title 165
###begin article-title 166
BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
###end article-title 166
###begin article-title 167
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.
###end article-title 167
###begin article-title 168
Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development.
###end article-title 168
###begin article-title 169
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation.
###end article-title 169
###begin article-title 170
BMP signalling in craniofacial development.
###end article-title 170
###begin article-title 171
Msx homeobox gene family and craniofacial development.
###end article-title 171
###begin article-title 172
Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures.
###end article-title 172
###begin article-title 173
Regulation of osteoblast differentiation by transcription factors.
###end article-title 173
###begin article-title 174
Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5.
###end article-title 174
###begin article-title 175
Reciprocal roles of Msx2 in regulation of osteoblast and adipocyte differentiation.
###end article-title 175
###begin article-title 176
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
###end article-title 176
###begin article-title 177
The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.
###end article-title 177
###begin article-title 178
Developmental regulation of the growth plate.
###end article-title 178
###begin article-title 179
Msx2 promotes late stages of chondrocyte differentiation by upregulating Ihh expression.
###end article-title 179
###begin article-title 180
###xml 35 41 <span type="species:ncbi:9606">humans</span>
Claudins in occluding junctions of humans and flies.
###end article-title 180
###begin article-title 181
Tight junctions and cell polarity.
###end article-title 181
###begin article-title 182
TGF-beta and epithelial-to-mesenchymal transitions.
###end article-title 182
###begin article-title 183
Enamel knots as signaling centers linking tooth morphogenesis and odontoblast differentiation.
###end article-title 183
###begin article-title 184
The cutting-edge of mammalian development; how the embryo makes teeth.
###end article-title 184
###begin article-title 185
The role of growth factors in tooth development.
###end article-title 185
###begin article-title 186
###xml 81 86 <span type="species:ncbi:9606">human</span>
Transforming growth-factor-beta stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in-vitro.
###end article-title 186
###begin article-title 187
Fibroblast heterogeneity: more than skin deep.
###end article-title 187
###begin article-title 188
Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.
###end article-title 188
###begin article-title 189
Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta.
###end article-title 189
###begin article-title 190
Osteogenesis imperfecta.
###end article-title 190
###begin article-title 191
Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2.
###end article-title 191
###begin article-title 192
Determination of the molecular basis of Marfan syndrome: a growth industry.
###end article-title 192
###begin article-title 193
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.
###end article-title 193
###begin article-title 194
Features of a Smad3 MH1-DNA complex. Roles of water and zinc in DNA binding.
###end article-title 194
###begin article-title 195
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
Targeting of the mouse Slc39a2 (Zip2) gene reveals highly cell-specific patterns of expression, and unique functions in zinc, iron, and calcium homeostasis.
###end article-title 195
###begin article-title 196
Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells.
###end article-title 196
###begin article-title 197
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Identification of mouse SLC39A8 as the transporter responsible for cadmium-induced toxicity in the testis.
###end article-title 197
###begin article-title 198
Metallochaperones: Bind and deliver.
###end article-title 198
###begin article-title 199
BMP signaling and early embryonic patterning.
###end article-title 199
###begin article-title 200
A gene-targeting approach for functional characterization of KIAA genes encoding extremely large proteins.
###end article-title 200
###begin article-title 201
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.
###end article-title 201
###begin article-title 202
Extracellular compartments in collagen fibril and bundle formation in the developing tendon.
###end article-title 202
###begin article-title 203
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type.
###end article-title 203
###begin article-title 204
###xml 122 130 <span type="species:ncbi:9606">patients</span>
Brittle cornea syndrome and its delineation from the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI): report on 23 patients and review of the literature.
###end article-title 204
###begin article-title 205
Urinary pyridinoline cross-links in Ehlers-Danlos syndrome type VI.
###end article-title 205
###begin p 206
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 206
###begin p 207
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan; by the Swiss National Foundation (grant no. 3100A0-100485); and by German BMBF Rare Diseases network SKELNET (Project GFGN01141901).
###end p 207

